Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB is a Private limited company (Ltd.) registered in Sweden under 5568738586, and its current status with Swedish Companies Registration Office (Bolagsverket) is active. The company was incorporated on 30 November 2011 and lists its registered address as STOCKHOLM, Sweden. 1 shareholder is on record for Infant Bacterial Therapeutics AB, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Swedish Companies Registration Office (Bolagsverket) and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
Shareholders of Infant Bacterial Therapeutics AB
One shareholder is currently on record for Infant Bacterial Therapeutics AB, filed with Swedish Companies Registration Office (Bolagsverket). The largest of these is TIFF Multi-Asset Fund, holding 83.9% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data-provider feed — rows as supplied to Zavia for Swedish Companies Registration Office (Bolagsverket), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| TIFF Multi-Asset Fund | 83.9% | Swedish Companies Registration Office (Bolagsverket) |
Officers
5
Directors and officers of Infant Bacterial Therapeutics AB
Three of the 5 officer records shown for Infant Bacterial Therapeutics AB are current appointments, filed with Swedish Companies Registration Office (Bolagsverket). Peter Michael Rothschild, Karin Margareta Hagman and Urban Ivar Strindlöv all serve as Director. The remaining 2 records shown (Jan Anders Fredrik Lovén and Jan Totte Dahlin) are former appointments that have since been resigned. Management authority at Infant Bacterial Therapeutics AB sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 12 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Data-provider feed — rows as supplied to Zavia for Swedish Companies Registration Office (Bolagsverket), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Group Structure
Group structure of Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- IBT Baby AB (Sweden)
Data availability
Those 1 subsidiary spans Sweden jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Data-provider feed — rows as supplied to Zavia for Swedish Companies Registration Office (Bolagsverket), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Infant Bacterial Therapeutics AB
Sweden
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Infant Bacterial Therapeutics AB?
One shareholder is currently on record for Infant Bacterial Therapeutics AB, filed with Swedish Companies Registration Office (Bolagsverket). The largest of these is TIFF Multi-Asset Fund, holding 83.9% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Infant Bacterial Therapeutics AB's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Infant Bacterial Therapeutics AB is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Infant Bacterial Therapeutics AB have on record?
1 shareholder is shown on record for Infant Bacterial Therapeutics AB.
What is Infant Bacterial Therapeutics AB's company registration number?
Infant Bacterial Therapeutics AB's registration number is 5568738586, filed with Swedish Companies Registration Office (Bolagsverket) in Sweden. Its current status on the register is active.
Is Infant Bacterial Therapeutics AB still an active company?
Infant Bacterial Therapeutics AB's status on Swedish Companies Registration Office (Bolagsverket) is listed as active.
When was Infant Bacterial Therapeutics AB incorporated?
Infant Bacterial Therapeutics AB was incorporated on 30 November 2011, according to Swedish Companies Registration Office (Bolagsverket).
What is Infant Bacterial Therapeutics AB's registered address?
The registered address on file for Infant Bacterial Therapeutics AB is STOCKHOLM, Sweden.
What legal structure is Infant Bacterial Therapeutics AB registered as?
Infant Bacterial Therapeutics AB is registered as a Private limited company (Ltd.) in Sweden.
Who are the officers/directors of Infant Bacterial Therapeutics AB?
Three of the 5 officer records shown for Infant Bacterial Therapeutics AB are current appointments, filed with Swedish Companies Registration Office (Bolagsverket). Peter Michael Rothschild, Karin Margareta Hagman and Urban Ivar Strindlöv all serve as Director. The remaining 2 records shown (Jan Anders Fredrik Lovén and Jan Totte Dahlin) are former appointments that have since been resigned. Management authority at Infant Bacterial Therapeutics AB sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Infant Bacterial Therapeutics AB have a parent company or subsidiaries?
Infant Bacterial Therapeutics AB has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Those 1 subsidiary spans Sweden jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Infant Bacterial Therapeutics AB's ownership over time?
This profile reflects a point-in-time snapshot from Swedish Companies Registration Office (Bolagsverket). Zavia's monitoring API can track changes to Infant Bacterial Therapeutics AB's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Infant Bacterial Therapeutics AB's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Sweden, so records like Infant Bacterial Therapeutics AB's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Swedish Companies Registration Office (Bolagsverket) and was last synced on 28 September 2026.